$19.16
6.12% yesterday
NYSE, Nov 06, 10:00 pm CET
ISIN
US90328M1071
Symbol
USNA

USANA Health Sciences, Inc. Target price 2025 - Analyst rating & recommendation

USANA Health Sciences, Inc. Classifications & Recommendation:

Hold
50%
Sell
50%

USANA Health Sciences, Inc. Price Target

Target Price $39.78
Price $19.16
Potential
Number of Estimates 3
3 Analysts have issued a price target USANA Health Sciences, Inc. 2026 . The average USANA Health Sciences, Inc. target price is $39.78. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 0 Analysts recommend USANA Health Sciences, Inc. to buy, 3 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the USANA Health Sciences, Inc. stock has an average upside potential 2026 of . Most analysts recommend the USANA Health Sciences, Inc. stock at Sell or hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 854.50 938.82
7.22% 9.87%
EBITDA Margin 9.46% 12.23%
17.60% 29.24%
Net Margin 4.92% 3.43%
28.98% 30.27%

3 Analysts have issued a sales forecast USANA Health Sciences, Inc. 2025 . The average USANA Health Sciences, Inc. sales estimate is

$939m
Unlock
. This is
2.87% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$966m 5.89%
Unlock
, the lowest is
$902m 1.17%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $855m 7.22%
2025
$939m 9.87%
Unlock
2026
$921m 1.91%
Unlock
2027
$941m 2.15%
Unlock

3 USANA Health Sciences, Inc. Analysts have issued a net profit forecast 2025. The average USANA Health Sciences, Inc. net profit estimate is

$32.2m
Unlock
. This is
89.76% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$33.2m 95.35%
Unlock
, the lowest is
$31.0m 82.28%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $42.0m 34.11%
2025
$32.2m 23.29%
Unlock
2026
$39.1m 21.37%
Unlock
2027
$51.4m 31.43%
Unlock

Net Margin

2024 4.92% 28.98%
2025
3.43% 30.27%
Unlock
2026
4.25% 23.91%
Unlock
2027
5.47% 28.71%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 2.19 1.76
33.64% 19.63%
P/E 10.86
EV/Sales 0.22

3 Analysts have issued a USANA Health Sciences, Inc. forecast for earnings per share. The average USANA Health Sciences, Inc. EPS is

$1.76
Unlock
. This is
91.30% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$1.82 97.83%
Unlock
, the lowest is
$1.70 84.78%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $2.19 33.64%
2025
$1.76 19.63%
Unlock
2026
$2.14 21.59%
Unlock
2027
$2.82 31.78%
Unlock

P/E ratio

Current 20.83 58.05%
2025
10.86 47.85%
Unlock
2026
8.94 17.68%
Unlock
2027
6.81 23.83%
Unlock

Based on analysts' sales estimates for 2025, the USANA Health Sciences, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.22 45.00%
2025
0.22 0.86%
Unlock
2026
0.22 1.93%
Unlock
2027
0.22 2.11%
Unlock

P/S ratio

Current 0.38 53.47%
2025
0.37 2.79%
Unlock
2026
0.38 1.93%
Unlock
2027
0.37 2.08%
Unlock

Current USANA Health Sciences, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
DA Davidson
Locked
Locked
Locked Feb 27 2025
DA Davidson
Locked
Locked
Locked Jan 02 2025
DA Davidson
Locked
Locked
Locked Oct 23 2024
Analyst Rating Date
Locked
DA Davidson:
Locked
Locked
Feb 27 2025
Locked
DA Davidson:
Locked
Locked
Jan 02 2025
Locked
DA Davidson:
Locked
Locked
Oct 23 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today